Skip to content

Clinical efficacy evaluation of intelligent governor moxibustion equipment in the treatment of asthma patients

Clinical efficacy evaluation of intelligent governor moxibustion equipment in the treatment of asthma patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001612
Enrollment
Unknown
Registered
2025-08-28
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Traditional Du moxibustion:1 Traditional Du moxibustion 2 ICS-LABA drugs were used on demand
Intelligent Du moxibustion bed:1 Intelligent Du-moxibustion treatment 2 ICS-LABA drugs were used on demand
Western medicine group:ICS-LABA drugs were used on demand for 6 weeks.

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: A. Meet the above western medicine diagnostic criteria for asthma ; b. In line with the above diagnostic criteria for asthma in traditional Chinese medicine ; c. Age between 60 and 75 years old men and women are not limited ; d. Has a fixed contact with the possibility of follow-up good compliance ; e. Signed informed consent volunteer subjects.

Exclusion criteria

Exclusion criteria: ( 1 ) combined with other serious heart and lung diseases bronchiectasis pleural lesions ; ( 2 ) patients with severe primary diseases such as severe liver and kidney injury mental illness and malignant tumor ; ( 3 ) Those who are allergic to research drugs and excipients ; ( 4 ) the injury of skin damage or other diseases affect the injury of local medication ; ( 5 ) women in lactation pregnancy or preparing for pregnancy ; ( 6 ) those who cannot give full informed consent due to intellectual or behavioral disorders ; ( 7 ) According to the judgment of the researcher other lesions that reduce the possibility of enrollment or complicate the enrollment such as frequent changes in the working environment are likely to cause loss of follow-up ; ( 8 ) Subjects who are undergoing other clinical research projects ; ( 9 ) Patients with acute attack.

Design outcomes

Primary

MeasureTime frame
pulmonary function;Asthma control level ( ACT ) score;Exhaled nitric oxide ( FeNO );

Secondary

MeasureTime frame
smoke dust concentration;symptom-limited test;skin temperature;

Countries

China

Contacts

Public ContactLanying liu

Acupuncture Rehabilitation Department of Jiangsu Provincial Hospital of Traditional Chinese Medicine

bluelanying@163.com+86 137 7062 5942

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026